I think she is going up from here till the record date as Inst. Buyers will scramble to add with low float to take advantage of future options which are going to be at ridiculous price.
Another reason is, Cantrixil initial indication is for metastatic ovarian cancer and if it works, people will be surprised how quick it will be to get approved since there is no alternative for stage 4 cancer other than death. Just like Orphan Drug Designation, I think thing will move very fast.
is not it come down to what this Company about?? If you look at the history, this novel approach they are working on did not just pop overnight, I think they have been already working on for 20 years...trial comes at the end baby.
I am excited about total novel approach of killing stem cells without affecting normal cells. It is very cool, When CEO himself injects the drug, I think it means something.
What do you think??
But, I disagree with your prediction about PPS. I see rebound at ASX tonight, especially with options, temptations are going to be much higher to buy prior to May Deadline.
with his Company's Drug....I think it means something.
Very Very Very Interesting. It is very very tempting to add shares at this level even though I will not have right to add more on options.
1) Imagine if Big Boys Start stepping in...(Since they will have right for options prior to May) in USA
2) Imagine PPS rebounds in ASX..
I think this will recover much sooner than people think....
Hello Mr. Bu,
How are you?
I accumulated little of ABAC.......GERN has cooled down lately but I am in GERN for long tern. I accumulated NVGN...very very interesting Biotech, catching lots of fire lately...Dr. Kelly and team has been working on this novel agents which work on cancer stem cells for last 20 years and ready to roll in with trials in Australia and USA .
I think it is up on news just released.
Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain CancerPR Newswire(Thu 9:43PM EDT)
So, I was able to get response from IR as following.
This is Tina Xiao, the IR representative for ABAC. I am currently in a business trip in China, so the US cell could not be reached, sorry for the inconvenience that may caused.
The Company is doing great, as we reported in annual report on March 18, 2015,
- Revenues grew 40% to a record level of $14.51 million for the fourth quarter of 2014
- Both gross margin and net income reached their highest levels in more than three years
- The newly acquired subsidiaries, Hang-ao and OV Orange, contributed $3.31 million, or 23% of total revenues in the fourth quarter of 2014
The Company will publicly release its First Quarter 2015 Results in the coming May. I will let you know for any updates, thanks.
Again, thanks for your supports for ABAC.
Tina works for following Co. which is getting paid by ABAC for investor relation.
I tried to sell at 1.95 and then 1.90 and there it goes Price down....
I will hold.
I think uptrend should continue. What do you think?
low SP and low liquidity are likely from
1) Chinese Co
2) New management
But Facts are
1) This micro cap Co never misses to report its quarterly and annual financial report
2) tried their best to keep their investors informed
3) they have skin at from 2.00 - 2.40 $ range
4) Excellent Diversification and Excellent Growth Prospects going forward.
Hey, Great to see you.
Yes, I know your name. I think Poster name Irishtrader put on a show there. I remember she mentioned Basket study which indicates Imetelstat if works in blast phase....I can be indicated for any Leukemia with blast phase in which Mortality is extremely high without much treatment option.
Sorry Oinkers, not intended to bore you folks.
I love what I see going forward on GERN Board. Lots of positive vibes and positve energy flowing in.
Great to see you.